Literature DB >> 11498948

[Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide].

H S Feng1, Y M Zang, M Z Zhu, J M Pei, Y M Wang, L Wang, P T Shi.   

Abstract

The vasorelaxing effects of vasonatrin peptide (VNP), C-type natriuretic peptide (CNP) and atrial natriuretic peptide (ANP) on isolated rat pulmonary artery, abdominal aorta and celiac vein were measured by in vitro perfusion. The results showed that VNP, CNP and ANP caused concentration-dependent relaxation in isolated rat pulmonary artery, abdominal aorta and celiac vein with endothelium or without endothelium. The maximal responses (Rmax) of VNP were (76 +/- 17)%, (51 +/- 14)% and (62 +/- 14)% in pulmonary artery, abdominal aorta and celiac vein with endothelium respectively, whereas those of CNP were (31 +/- 8)%, (22 +/- 7)% and (41 +/- 8)%, and ANP (38 +/- 10)%, (41 +/- 10)% and (11 +/- 4)%. The median effective concentration (EC50) of VNP were 16 +/- 11, 35 +/- 18 and 12 +/- 8 nmol/L in pulmonary artery, abdominal aorta and celiac vein with endothelium respectively, while those of CNP were 148 +/- 112, 299 +/- 84 and 14 +/- 12 nmol/L, and ANP 66 +/- 47, 16 +/- 15 and 909 +/- 445 nmol/L. VNP were more effective than CNP and ANP, and the differences were statistically significant (P < 0.05-0.01). The potency of these peptides for relaxing the blood vessels can be summarized as: VNP > ANP > or = CNP for pulmonary artery; VNP > ANP > CNP for abdominal aorta; VNP > CNP > ANP for celiac vein. There was no significant difference between vessels with intact endothelium and those denuded of endothelium (P > 0.05).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11498948

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  3 in total

1.  Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.

Authors:  B-Y Chen; R Tie; P Qu; M-Z Zhu; X-X Zhu; J Jin; J Yu
Journal:  J Endocrinol Invest       Date:  2011-05-17       Impact factor: 4.256

Review 2.  Designer natriuretic peptides.

Authors:  Candace Y W Lee; Hsiao Lieu; John C Burnett
Journal:  J Investig Med       Date:  2009-01       Impact factor: 2.895

3.  Innovative Therapeutics: Designer Natriuretic Peptides.

Authors:  Laura M G Meems; John C Burnett
Journal:  JACC Basic Transl Sci       Date:  2016-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.